Tetraphase Pharmaceuticals, Inc. (TTPH): Price and Financial Metrics
Tetraphase Pharmaceuticals, Inc. (TTPH)
Today's Latest Price: $2.29 USD
0.11 (5.05%)
Updated Feb 18 8:00pm
Add TTPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
TTPH Stock Summary
- With a market capitalization of $8,203,041, Tetraphase Pharmaceuticals Inc has a greater market value than merely 3.78% of US stocks.
- With a year-over-year growth in debt of -84.52%, Tetraphase Pharmaceuticals Inc's debt growth rate surpasses merely 3.2% of about US stocks.
- In terms of volatility of its share price, TTPH is more volatile than 98.68% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Tetraphase Pharmaceuticals Inc, a group of peers worth examining would be GEVO, GPRO, AMRS, TTOO, and EXTR.
- TTPH's SEC filings can be seen here. And to visit Tetraphase Pharmaceuticals Inc's official web site, go to www.tphase.com.
TTPH Daily Price Range
TTPH 52-Week Price Range
TTPH Stock Price Chart More Charts
TTPH Price/Volume Stats
| Current price | $2.29 | 52-week high | $29.00 |
| Prev. close | $2.18 | 52-week low | $1.99 |
| Day low | $2.07 | Volume | 235,400 |
| Day high | $2.32 | Avg. volume | 187,475 |
| 50-day MA | $2.51 | Dividend yield | N/A |
| 200-day MA | $6.72 | Market Cap | 7.94M |
Tetraphase Pharmaceuticals, Inc. (TTPH) Company Bio
Tetraphase Pharmaceuticals is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create antibiotics for serious and life-threatening MDR bacterial infections. The company was founded in 2006 and is based in Watertown, Massachusetts.
Top Stories View All
Best & Worst Performing Stock Industries for February 18, 2020
Best & Worst Performing Small Cap Stocks for February 18, 2020
Best & Worst Performing Mid Cap Stocks for February 18, 2020
Best & Worst Performing Large Cap Stocks for February 18, 2020
Best & Worst Performing Mega Cap Stocks for February 18, 2020
View All Top Stories
Loading social stream, please wait...